Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Herstellerkennzeichnung
Die Herstellerinformationen sind derzeit nicht verfügbar.
Inhaltsangabe
Thrombophilia and thrombogenesis.- The molecular mechanisms of inherited thrombophilia.- Hypercoagulative syndrome: Molecular markers for the identification of cardiovascular patients at risk.- Clinical implications of the new understanding of thrombophilia.- The clinical syndrome of acute pulmonary embolism.- Mechanisms of ventilation-perfusion mismatch and hemodynamic alterations in acute and chronic pulmonary embolism.- Clinical course and prognosis of acute pulmonary embolism.- Clinical implications of a patent foramen ovale in patients with massive pulmonary embolism.- The value of echocardiography in the diagnostic work-up of patients with suspected acute pulmonary embolism.- Scintigraphy-ventilation/perfusion scanning and imaging of the embolus.- MR-angiography in the diagnosis of pulmonary embolism.- Anticoagulation and fibrinolysis.- Anticoagulation.- Mechanism of blood coagulation. Newer aspects of anticoagulant and antithrombotic therapy.- Low molecular weight heparins - Pharmacological principles and indications in clinical practice.- Heparin-induced thrombocytopenia.- New developments in the thrombolytic therapy of venous thrombosis.- The risk of recurrent venous thromboembolic disease - implications for treatment.- A randomized trial of the effect of low molecular weight heparin vs. warfarin on mortality in the long-term treatment of proximal vein thrombosis.- Fibrinolysis.- Thrombolytic therapy in pulmonary embolism. Which patients should be treated, which regimen should be used?.- Thrombolytic treatment of pulmonary embolism: Life-saving option or unacceptable risk?.- Surgical treatment of acute pulmonary embolism.
Thrombophilia and thrombogenesis.- The molecular mechanisms of inherited thrombophilia.- Hypercoagulative syndrome: Molecular markers for the identification of cardiovascular patients at risk.- Clinical implications of the new understanding of thrombophilia.- The clinical syndrome of acute pulmonary embolism.- Mechanisms of ventilation-perfusion mismatch and hemodynamic alterations in acute and chronic pulmonary embolism.- Clinical course and prognosis of acute pulmonary embolism.- Clinical implications of a patent foramen ovale in patients with massive pulmonary embolism.- The value of echocardiography in the diagnostic work-up of patients with suspected acute pulmonary embolism.- Scintigraphy-ventilation/perfusion scanning and imaging of the embolus.- MR-angiography in the diagnosis of pulmonary embolism.- Anticoagulation and fibrinolysis.- Anticoagulation.- Mechanism of blood coagulation. Newer aspects of anticoagulant and antithrombotic therapy.- Low molecular weight heparins - Pharmacological principles and indications in clinical practice.- Heparin-induced thrombocytopenia.- New developments in the thrombolytic therapy of venous thrombosis.- The risk of recurrent venous thromboembolic disease - implications for treatment.- A randomized trial of the effect of low molecular weight heparin vs. warfarin on mortality in the long-term treatment of proximal vein thrombosis.- Fibrinolysis.- Thrombolytic therapy in pulmonary embolism. Which patients should be treated, which regimen should be used?.- Thrombolytic treatment of pulmonary embolism: Life-saving option or unacceptable risk?.- Surgical treatment of acute pulmonary embolism.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
